[关键词]
[摘要]
[ 摘要 ] 目的 探究匹多莫德治疗呼吸系统反复感染患儿的临床效果。 方法 选取 2021 年 1 月至 2022 年 1 月 山东省第二人民医院收治的 80 例呼吸系统反复感染患儿,按照随机数字表法将其分为对照组(40 例)与观 察组(40 例),对照组予常规治疗,观察组予匹多莫德治疗,比较两组的治疗效果。 结果 观察组治疗总有效率 高于对照组,差异有统计学意义(P < 0.05)。治疗后,观察组临床症状评分、炎症因子水平低于对照组,差异 有统计学意义(P < 0.05)。 结论 匹多莫德治疗呼吸系统反复感染患儿的临床效果显著,值得推广。
[Key word]
[Abstract]
[Abstract] Objective To explore the clinical effect of Pitotimod in the treatment of children with recurrent respiratory infection. Methods A total of 80 children with recurrent respiratory infection in Shandong Second Provincial General Hospital from January 2021 to January 2022 were selected and divided into control group (40 cases) and observation group (40 cases) according to the random number table method. The control group was given conventional treatment, and the observation group was treated with Pidotimod. The therapeutic effect of the two groups was compared. Results The overall response rate of observation group was higher than that of control group, the difference was statistically significant (P < 0.05). After treatment the clinical symptom score and inflammatory factor levels in the observation group were lower than those in the control group (P < 0.05). Conclusion Pitotimod treating children with recurrent respiratory infection has significant clinical effect and is worth promoting.
[中图分类号]
R725.6
[基金项目]